Synergistic effects of the KDM4C inhibitor SD70 and the menin inhibitor MI-503 against MLL::AF9-driven acute myeloid leukaemia. Zhu W, Ding Y, Huang W, Guo N, et al. Br J Haematol 2024;205:568-579.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu W, Ding Y, Huang W, Guo N, et al. Synergistic effects of the KDM4C inhibitor SD70 and the menin inhibitor MI-503 against MLL::AF9-driven acute myeloid leukaemia. Br J Haematol 2024;205:568-579.
PMID: 38877874